Search Results - "Gilhus, N. E."

Refine Results
  1. 1

    Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence by Gilhus, N. E., Hong, Y.

    Published in European journal of neurology (01-12-2018)
    “…Females with myasthenia gravis (MG) worry about their disease having negative consequences for their children. Autoimmune disease mechanisms, treatment and…”
    Get full text
    Journal Article
  2. 2

    EFNS/ENS Guidelines for the treatment of ocular myasthenia by Kerty, E., Elsais, A., Argov, Z., Evoli, A., Gilhus, N. E.

    Published in European journal of neurology (01-05-2014)
    “…Background and purpose The symptoms of acquired autoimmune ocular myasthenia are restricted to the extrinsic eye muscles, causing double vision and drooping…”
    Get full text
    Journal Article
  3. 3

    Myasthenia gravis and risks for comorbidity by Gilhus, N. E., Nacu, A., Andersen, J. B., Owe, J. F.

    Published in European journal of neurology (01-01-2015)
    “…Myasthenia gravis (MG) is an autoimmune disorder leading to skeletal muscle weakness and fatigability. MG subgroups are defined according to pathogenetic…”
    Get full text
    Journal Article
  4. 4

    Guidelines for treatment of autoimmune neuromuscular transmission disorders by Skeie, G. O., Apostolski, S., Evoli, A., Gilhus, N. E., Illa, I., Harms, L., Hilton-Jones, D., Melms, A., Verschuuren, J., Horge, H. W.

    Published in European journal of neurology (01-07-2010)
    “…Background:  Important progress has been made in our understanding of the autoimmune neuromuscular transmission (NMT) disorders; myasthenia gravis (MG),…”
    Get full text
    Journal Article
  5. 5

    Complications during pregnancy in women with epilepsy: population‐based cohort study by Borthen, I, Eide, MG, Veiby, G, Daltveit, AK, Gilhus, NE

    “…Objective  To investigate whether women with epilepsy have an increased risk of complications during pregnancy and to explore the impact of antiepileptic drug…”
    Get full text
    Journal Article
  6. 6

    Obstetric outcome in women with epilepsy: a hospital‐based, retrospective study by Borthen, I, Eide, MG, Daltveit, AK, Gilhus, NE

    “…Please cite this paper as: Borthen I, Eide M, Daltveit A, Gilhus N. Obstetric outcome in women with epilepsy: a hospital‐based, retrospective study. BJOG…”
    Get full text
    Journal Article
  7. 7

    Antititin antibody in early- and late-onset myasthenia gravis by Szczudlik, P., Szyluk, B., Lipowska, M., Ryniewicz, B., Kubiszewska, J., Dutkiewicz, M., Gilhus, N. E., Kostera-Pruszczyk, A.

    Published in Acta neurologica Scandinavica (01-10-2014)
    “…Objectives Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against neuromuscular junction proteins, 85% of patients have antibodies…”
    Get full text
    Journal Article
  8. 8

    HLA and MuSK‐positive myasthenia gravis: A systemic review and meta‐analysis by Hong, Y., Li, H.‐F., Romi, F., Skeie, G. O., Gilhus, N. E.

    Published in Acta neurologica Scandinavica (01-09-2018)
    “…Objectives Myasthenia gravis (MG) represents a spectrum of clinical subtypes with differences in disease mechanisms and treatment response. MG with…”
    Get full text
    Journal Article
  9. 9

    EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases by Elovaara, I., Apostolski, S., Van Doorn, P., Gilhus, N. E., Hietaharju, A., Honkaniemi, J., Van Schaik, I. N., Scolding, N., Soelberg Sørensen, P., Udd, B.

    Published in European journal of neurology (01-09-2008)
    “…Despite high‐dose intravenous immunoglobulin (IVIG) is widely used in treatment of a number of immune‐mediated neurological diseases, the consensus on its…”
    Get full text
    Journal Article
  10. 10

    Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force by Deisenhammer, F., Bartos, A., Egg, R., Gilhus, N. E., Giovannoni, G., Rauer, S., Sellebjerg, F.

    Published in European journal of neurology (01-09-2006)
    “…A great variety of neurological diseases require investigation of cerebrospinal fluid (CSF) to prove the diagnosis or to rule out relevant differential…”
    Get full text
    Journal Article
  11. 11

    Neurological disorders in the Global Burden of Disease 2010 study by Stovner, L. J., Hoff, J. M., Svalheim, S., Gilhus, N. E.

    Published in Acta neurologica Scandinavica (01-04-2014)
    “…Background The Global Burden of Disease study (GBD) is a large international initiative to collect and systematize data on disease burden expressed in…”
    Get full text
    Journal Article
  12. 12

    A 50-year follow-up of the incidence of traumatic spinal cord injuries in Western Norway by Hagen, E M, Eide, G E, Rekand, T, Gilhus, N E, Gronning, M

    Published in Spinal cord (01-04-2010)
    “…Study design: Retrospective population-based epidemiological study. Objective: To assess the prevalence and temporal trends in the incidence of traumatic…”
    Get full text
    Journal Article
  13. 13

    Pregnancy, delivery, and birth outcome in women with multiple sclerosis by DAHL, J, MYHR, K.-M, DALTVEIT, A. K, HOFF, J. M, GILHUS, N. E

    Published in Neurology (27-12-2005)
    “…Using data from the compulsory Medical Birth Registry of Norway, the authors investigated the effect of maternal multiple sclerosis (MS) on pregnancy,…”
    Get full text
    Journal Article
  14. 14

    Delivery outcome of women with epilepsy:a population‐based cohort study by Borthen, I, Eide, MG, Daltveit, AK, Gilhus, NE

    “…Please cite this paper as: Borthen I, Eide M, Daltveit A, Gilhus N. Delivery outcome of women with epilepsy: a population‐based cohort study.
BJOG…”
    Get full text
    Journal Article
  15. 15

    EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force by Farbu, E., Gilhus, N. E., Barnes, M. P., Borg, K., De Visser, M., Driessen, A., Howard, R., Nollet, F., Opara, J., Stalberg, E.

    Published in European journal of neurology (01-08-2006)
    “…Post‐polio syndrome (PPS) is characterized by new or increased muscular weakness, atrophy, muscle pain and fatigue several years after acute polio. The aim of…”
    Get full text
    Journal Article
  16. 16

    Myasthenia gravis: clinical, immunological, and therapeutic advances by Romi, F., Gilhus, N. E., Aarli, J. A.

    Published in Acta neurologica Scandinavica (01-02-2005)
    “…We give an update on clinical, immunological, and therapeutic advances in the field of myasthenia gravis, including a summary of suggested therapeutic…”
    Get full text
    Journal Article
  17. 17

    Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004 by Brainin, M., Barnes, M., Baron, J.-C., Gilhus, N. E., Hughes, R., Selmaj, K., Waldemar, G.

    Published in European journal of neurology (01-09-2004)
    “…Since the publication of the first EFNS task force reports in 1997, a total of 20 evidence‐based guidelines for the treatment and management of neurological…”
    Get full text
    Journal Article
  18. 18

    Diagnostic coding accuracy for traumatic spinal cord injuries by Hagen, E M, Rekand, T, Gilhus, N E, Gronning, M

    Published in Spinal cord (01-05-2009)
    “…Study design: Retrospective register study enhanced and verified by medical records. Objectives: To study whether electronic searches of discharge diagnosis…”
    Get full text
    Journal Article
  19. 19

    EEG background activity described by a large computerized database by Aurlien, H, Gjerde, I.O, Aarseth, J.H, Eldøen, G, Karlsen, B, Skeidsvoll, H, Gilhus, N.E

    Published in Clinical neurophysiology (01-03-2004)
    “…Objective: To show how our newly developed software for classification and storage of visually routinely assessed EEGs are used to evaluate the general…”
    Get full text
    Journal Article
  20. 20

    Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001 by Owe, J F, Daltveit, A K, Gilhus, N E

    “…Objective: This study investigated the causes of death among patients with myasthenia gravis (MG), with emphasis on respiratory tract and cardiac disease…”
    Get full text
    Journal Article